Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard

被引：2
|
作者：
Yalman, Deniz [1 ]
Selek, Ugur [2 ,3 ]
机构：
[1] Ege Univ, Sch Med, Dept Radiat Oncol, 35100 Bornova, Izmir, Turkey
[2] Koc Univ, Sch Med, Dept Radiat Oncol, Istanbul, Turkey
[3] Univ Texas Houston, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77004 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2015年 / 3卷 / 11期
关键词：
D O I：
10.3978/j.issn.2305-5839.2015.06.23
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)
    Islam, Mohammad
    Cyriac, Abby
    Durga, Tarun
    Sarkodie, Thomas
    Begum, Gulshad
    Evans, Joanne
    Palvai, Sreekanth
    Tun, Khin
    LUNG CANCER, 2023, 178 : S55 - S55
  • [2] Stereotactic Ablative Radiotherapy (SABR) in Potentially Operable Patients with Stage I Non-small Cell Lung Cancer
    Lagerwaard, F. J.
    Verstegen, N. E.
    Haasbeek, C. J. A.
    Slotman, B. J.
    Smit, E. F.
    Paul, M. A.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S79 - S80
  • [3] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN POTENTIALLY OPERABLE STAGE I NON-SMALL CELL LUNG CANCER PATIENTS
    Lagerwaard, Frank J.
    Verstegen, Naomi E.
    Haasbeek, Cornelis J.
    Slotman, Ben
    Paul, M. A.
    Smit, Egbert F.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S278 - S279
  • [4] CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)
    Leschenko, Y.
    Chebotareva, T.
    Spizhenko, N.
    Fedusenko, A.
    Sharaevskiy, O.
    Buryk, V.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S39 - S39
  • [5] Immune Activation in Early Stage Non-Small Cell Lung Cancer (NSCLC) following Stereotactic Ablative Radiotherapy (SABR) and Surgery
    Aerts, Joachim G.
    De Goeje, Pauline
    Schram, Merel
    Bezemer, Koen
    Kaijen-Lambers, Margaretha
    Hegmans, Joost
    De langen, Joop
    Maat, Alexander
    Nuyttens, Joost
    Hendriks, Rudi
    Smit, Egbert
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S326 - S326
  • [6] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [7] Preliminary results of prospective data for patients receiving stereotactic ablative radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC)
    Pickles, R. L.
    Iqbal, S.
    Atherton, P.
    Turnbull, H.
    Mcmenemin, R.
    Walker, C.
    Pilling, K.
    Muller, M.
    Mott, J.
    Mccallum, H.
    LUNG CANCER, 2016, 91 : S47 - S48
  • [8] STEREOTACTIC ABLATIVE RADIOTHERAPY OF EARLY STAGE NON-SMALL CELL LUNG CANCER
    Cvek, Jakub
    Feltl, David
    Knybel, Lukas
    Otahal, Bretislav
    Skacelikova, Eva
    Binarova, Andrea
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S537 - S537
  • [9] Experience of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC): an analysis of treatment response and survival outcome
    Iqbal, M. S.
    Pickles, R.
    Mackenzie, L.
    Burns, A.
    Turnbull, H.
    Atherton, P.
    LUNG CANCER, 2019, 127 : S73 - S73
  • [10] Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    Marar, M.
    Bryant, A. K.
    Nalawade, V.
    Das, M.
    Loo, B. W., Jr.
    Diehn, M.
    Chin, A. L.
    Murphy, J. D.
    Vitzthum, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E447 - E447
12345